Akebia Therapeutics, Inc. (AKBA)
Nasdaq: AKBA · CIK 0001517022 · United States
Every official Akebia Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open AKBA filings
Akebia Therapeutics, Inc. documents
- Akebia Therapeutics, Inc. 10-K 2026AKBA 10-K 2026: annual report for fiscal 2026
- Akebia Therapeutics, Inc. 10-K 2025AKBA 10-K 2025: annual report for fiscal 2025
- Akebia Therapeutics, Inc. 10-K 2024AKBA 10-K 2024: annual report for fiscal 2024
- Akebia Therapeutics, Inc. 10-K 2023AKBA 10-K 2023: annual report for fiscal 2023
- Akebia Therapeutics, Inc. 10-K 2022AKBA 10-K 2022: annual report for fiscal 2022
- Akebia Therapeutics, Inc. 10-Q 2026AKBA 10-Q 2026: quarterly report for fiscal 2026
- Akebia Therapeutics, Inc. 10-Q 2025AKBA 10-Q 2025: quarterly report for fiscal 2025
- Akebia Therapeutics, Inc. 10-Q 2024AKBA 10-Q 2024: quarterly report for fiscal 2024
- Akebia Therapeutics, Inc. 10-Q 2023AKBA 10-Q 2023: quarterly report for fiscal 2023
- Akebia Therapeutics, Inc. 10-Q 2022AKBA 10-Q 2022: quarterly report for fiscal 2022
- Akebia Therapeutics, Inc. 8-K 2026AKBA 8-K 2026: current report for fiscal 2026
- Akebia Therapeutics, Inc. 8-K 2025AKBA 8-K 2025: current report for fiscal 2025
- Akebia Therapeutics, Inc. 8-K 2024AKBA 8-K 2024: current report for fiscal 2024
- Akebia Therapeutics, Inc. 8-K 2023AKBA 8-K 2023: current report for fiscal 2023
- Akebia Therapeutics, Inc. 8-K 2022AKBA 8-K 2022: current report for fiscal 2022
- Akebia Therapeutics, Inc. DEF 14A 2026AKBA DEF 14A 2026: proxy statement for fiscal 2026
- Akebia Therapeutics, Inc. DEF 14A 2025AKBA DEF 14A 2025: proxy statement for fiscal 2025
- Akebia Therapeutics, Inc. DEF 14A 2024AKBA DEF 14A 2024: proxy statement for fiscal 2024
- Akebia Therapeutics, Inc. DEF 14A 2023AKBA DEF 14A 2023: proxy statement for fiscal 2023
- Akebia Therapeutics, Inc. DEF 14A 2022AKBA DEF 14A 2022: proxy statement for fiscal 2022
- Akebia Therapeutics, Inc. Form 4 2026AKBA Form 4 2026: insider trading filing for fiscal 2026
- Akebia Therapeutics, Inc. Form 4 2025AKBA Form 4 2025: insider trading filing for fiscal 2025
- Akebia Therapeutics, Inc. Form 4 2024AKBA Form 4 2024: insider trading filing for fiscal 2024
- Akebia Therapeutics, Inc. Form 4 2023AKBA Form 4 2023: insider trading filing for fiscal 2023
- Akebia Therapeutics, Inc. Form 4 2022AKBA Form 4 2022: insider trading filing for fiscal 2022
- Akebia Therapeutics, Inc. S-1 2026AKBA S-1 2026: registration statement for fiscal 2026
- Akebia Therapeutics, Inc. S-1 2025AKBA S-1 2025: registration statement for fiscal 2025
- Akebia Therapeutics, Inc. S-1 2024AKBA S-1 2024: registration statement for fiscal 2024
- Akebia Therapeutics, Inc. S-1 2023AKBA S-1 2023: registration statement for fiscal 2023
- Akebia Therapeutics, Inc. S-1 2022AKBA S-1 2022: registration statement for fiscal 2022
- Akebia Therapeutics, Inc. 13F 2026AKBA 13F 2026: institutional holdings for fiscal 2026
- Akebia Therapeutics, Inc. 13F 2025AKBA 13F 2025: institutional holdings for fiscal 2025
- Akebia Therapeutics, Inc. 13F 2024AKBA 13F 2024: institutional holdings for fiscal 2024
- Akebia Therapeutics, Inc. 13F 2023AKBA 13F 2023: institutional holdings for fiscal 2023
- Akebia Therapeutics, Inc. 13F 2022AKBA 13F 2022: institutional holdings for fiscal 2022
More companies